BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

289 related articles for article (PubMed ID: 15626820)

  • 1. The neuroprotective factor Wlds does not attenuate mutant SOD1-mediated motor neuron disease.
    Vande Velde C; Garcia ML; Yin X; Trapp BD; Cleveland DW
    Neuromolecular Med; 2004; 5(3):193-203. PubMed ID: 15626820
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Axonal and neuromuscular synaptic phenotypes in Wld(S), SOD1(G93A) and ostes mutant mice identified by fiber-optic confocal microendoscopy.
    Wong F; Fan L; Wells S; Hartley R; Mackenzie FE; Oyebode O; Brown R; Thomson D; Coleman MP; Blanco G; Ribchester RR
    Mol Cell Neurosci; 2009 Dec; 42(4):296-307. PubMed ID: 19683573
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human Cu/Zn superoxide dismutase (SOD1) overexpression in mice causes mitochondrial vacuolization, axonal degeneration, and premature motoneuron death and accelerates motoneuron disease in mice expressing a familial amyotrophic lateral sclerosis mutant SOD1.
    Jaarsma D; Haasdijk ED; Grashorn JA; Hawkins R; van Duijn W; Verspaget HW; London J; Holstege JC
    Neurobiol Dis; 2000 Dec; 7(6 Pt B):623-43. PubMed ID: 11114261
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Axonal involvement in the Wlds neuroprotective effect: analysis of pure motoneurons in a mouse model protected from motor neuron disease at a pre-symptomatic age.
    Simonin Y; Perrin FE; Kato AC
    J Neurochem; 2007 Apr; 101(2):530-42. PubMed ID: 17402973
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mutant Cu, Zn superoxide dismutase that causes motoneuron degeneration is present in mitochondria in the CNS.
    Higgins CM; Jung C; Ding H; Xu Z
    J Neurosci; 2002 Mar; 22(6):RC215. PubMed ID: 11886899
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhancing mitochondrial calcium buffering capacity reduces aggregation of misfolded SOD1 and motor neuron cell death without extending survival in mouse models of inherited amyotrophic lateral sclerosis.
    Parone PA; Da Cruz S; Han JS; McAlonis-Downes M; Vetto AP; Lee SK; Tseng E; Cleveland DW
    J Neurosci; 2013 Mar; 33(11):4657-71. PubMed ID: 23486940
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Motor neuron disease occurring in a mutant dynactin mouse model is characterized by defects in vesicular trafficking.
    Laird FM; Farah MH; Ackerley S; Hoke A; Maragakis N; Rothstein JD; Griffin J; Price DL; Martin LJ; Wong PC
    J Neurosci; 2008 Feb; 28(9):1997-2005. PubMed ID: 18305234
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endosomal accumulation of APP in wobbler motor neurons reflects impaired vesicle trafficking: implications for human motor neuron disease.
    Palmisano R; Golfi P; Heimann P; Shaw C; Troakes C; Schmitt-John T; Bartsch JW
    BMC Neurosci; 2011 Mar; 12():24. PubMed ID: 21385376
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Toxicity of familial ALS-linked SOD1 mutants from selective recruitment to spinal mitochondria.
    Liu J; Lillo C; Jonsson PA; Vande Velde C; Ward CM; Miller TM; Subramaniam JR; Rothstein JD; Marklund S; Andersen PM; Brännström T; Gredal O; Wong PC; Williams DS; Cleveland DW
    Neuron; 2004 Jul; 43(1):5-17. PubMed ID: 15233913
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The slow Wallerian degeneration gene, WldS, inhibits axonal spheroid pathology in gracile axonal dystrophy mice.
    Mi W; Beirowski B; Gillingwater TH; Adalbert R; Wagner D; Grumme D; Osaka H; Conforti L; Arnhold S; Addicks K; Wada K; Ribchester RR; Coleman MP
    Brain; 2005 Feb; 128(Pt 2):405-16. PubMed ID: 15644421
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Length-dependent axo-terminal degeneration at the neuromuscular synapses of type II muscle in SOD1 mice.
    Tallon C; Russell KA; Sakhalkar S; Andrapallayal N; Farah MH
    Neuroscience; 2016 Jan; 312():179-89. PubMed ID: 26592719
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Complete dissociation of motor neuron death from motor dysfunction by Bax deletion in a mouse model of ALS.
    Gould TW; Buss RR; Vinsant S; Prevette D; Sun W; Knudson CM; Milligan CE; Oppenheim RW
    J Neurosci; 2006 Aug; 26(34):8774-86. PubMed ID: 16928866
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuregulin 1 confers neuroprotection in SOD1-linked amyotrophic lateral sclerosis mice via restoration of C-boutons of spinal motor neurons.
    Lasiene J; Komine O; Fujimori-Tonou N; Powers B; Endo F; Watanabe S; Shijie J; Ravits J; Horner P; Misawa H; Yamanaka K
    Acta Neuropathol Commun; 2016 Feb; 4():15. PubMed ID: 26891847
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Axonal transport of mutant superoxide dismutase 1 and focal axonal abnormalities in the proximal axons of transgenic mice.
    Borchelt DR; Wong PC; Becher MW; Pardo CA; Lee MK; Xu ZS; Thinakaran G; Jenkins NA; Copeland NG; Sisodia SS; Cleveland DW; Price DL; Hoffman PN
    Neurobiol Dis; 1998 Jul; 5(1):27-35. PubMed ID: 9702785
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuroprotective effects of the Sigma-1 receptor (S1R) agonist PRE-084, in a mouse model of motor neuron disease not linked to SOD1 mutation.
    Peviani M; Salvaneschi E; Bontempi L; Petese A; Manzo A; Rossi D; Salmona M; Collina S; Bigini P; Curti D
    Neurobiol Dis; 2014 Feb; 62():218-32. PubMed ID: 24141020
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impairment of axonal transport in the axon hillock and the initial segment of anterior horn neurons in transgenic mice with a G93A mutant SOD1 gene.
    Sasaki S; Warita H; Abe K; Iwata M
    Acta Neuropathol; 2005 Jul; 110(1):48-56. PubMed ID: 15920660
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mouse motor neuron disease caused by truncated SOD1 with or without C-terminal modification.
    Watanabe Y; Yasui K; Nakano T; Doi K; Fukada Y; Kitayama M; Ishimoto M; Kurihara S; Kawashima M; Fukuda H; Adachi Y; Inoue T; Nakashima K
    Brain Res Mol Brain Res; 2005 Apr; 135(1-2):12-20. PubMed ID: 15857664
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mutant SOD1 causes motor neuron disease independent of copper chaperone-mediated copper loading.
    Subramaniam JR; Lyons WE; Liu J; Bartnikas TB; Rothstein J; Price DL; Cleveland DW; Gitlin JD; Wong PC
    Nat Neurosci; 2002 Apr; 5(4):301-7. PubMed ID: 11889469
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interleukin-6 Deficiency Does Not Affect Motor Neuron Disease Caused by Superoxide Dismutase 1 Mutation.
    Han Y; Ripley B; Serada S; Naka T; Fujimoto M
    PLoS One; 2016; 11(4):e0153399. PubMed ID: 27070121
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Slowing of axonal transport is a very early event in the toxicity of ALS-linked SOD1 mutants to motor neurons.
    Williamson TL; Cleveland DW
    Nat Neurosci; 1999 Jan; 2(1):50-6. PubMed ID: 10195180
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.